SCHEMBL18634220

SCHEMBL18634220

CC(=O)C(OC(=O)N1CCN(S(=O)(=O)c2ccc3ccccc3c2)CC1)C(F)(F)F

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 9/20 0.59
▸ ALDH1A1 P00352 4/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ LMNA P02545 2/20 0.56
▸ GAA P10253 2/20 0.56
▸ KMT2A Q03164 2/20 0.55
▸ MGLL Q99685 1/20 0.55
▸ MEN1 O00255 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ ATM Q13315 1/20 0.52
▸ PABPC1 P11940 1/20 0.52
▸ APOBEC3A P31941 1/20 0.52
▸ EIF4H Q15056 1/20 0.52
▸ APOBEC3G Q9HC16 1/20 0.52
▸ PKLR P30613 1/20 0.51
▸ HTT P42858 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20408703 0.87 PKM (0.65) PKMALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL15100848 0.87 PKM (0.61) PKMALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL18634273 0.87 MGLL (0.53) PKMALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL18634071 0.84 KMT2A (0.52) PKMALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL18634274 0.83 SMN1; SMN2 (0.58) PKMSMN1; SMN2LMNAGAAPKLR
SCHEMBL18634072 0.82 GPR183 (0.50) PKMSMN1; SMN2LMNAGAAKMT2A
SCHEMBL20411236 0.80 PKM (0.47) PKMSMN1; SMN2GAAMGLLPKLR
SCHEMBL18634077 0.80 LMNA (0.44) ALDH1A1SMN1; SMN2LMNAGAAKMT2A
SCHEMBL6790392 0.79 PKM (0.65) PKMALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL18711449 0.78 PKM (0.74) PKMALDH1A1SMN1; SMN2LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312499-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2023-10-05 — — US disclosed
US-11530189-B2 Carbamate compounds and methods of making and using same H. LUNDBECKA/S (DK) 2022-12-20 — — US disclosed
US-20210188793-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME LUNDBECK LA JOLLA RESEARCH CENTER, INC. 2021-06-24 — — US disclosed
US-11021453-B2 Carbamate compounds and methods of making and using same LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) 2021-06-01 — — US disclosed
US-20200270223-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2020-08-27 — — US disclosed
EP-3698782-A1 CARBAMATE COMPOUNDS FOR USE IN THERAPY Lundbeck La Jolla Research Center, Inc. (US) 2020-08-26 — — EP disclosed
US-20180208568-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2018-07-26 — — US disclosed
US-9957242-B2 Carbamate compounds and methods of making and using same THE SCRIPPS RESEARCH INSTITUTE (US) 2018-05-01 — — US disclosed
US-20170073320-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2017-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11530189-B2 Carbamate compounds and methods of making and using same ABHD6, ABHD16A, RABL6 PKM 3906/4885ALDH1A1 2487/4885SMN1; SMN2 2374/4885
US-11021453-B2 Carbamate compounds and methods of making and using same ABHD6, ABHD16A, RABL6 PKM 3805/4885ALDH1A1 2385/4885SMN1; SMN2 2659/4885
US-20210188793-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, RABL6 PKM 3906/4885ALDH1A1 2487/4885SMN1; SMN2 2374/4885
US-20200270223-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, NCEH1 PKM 4171/4885ALDH1A1 1712/4885SMN1; SMN2 1553/4885
US-20180208568-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, NCEH1 PKM 4171/4885ALDH1A1 1712/4885SMN1; SMN2 1553/4885
US-20230312499-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, RABL6 PKM 3906/4885ALDH1A1 2487/4885SMN1; SMN2 2374/4885
US-20170073320-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, NCEH1 PKM 4171/4885ALDH1A1 1712/4885SMN1; SMN2 1553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback